Characterization of the gene encoding the major secreted lysophospholipase A of Legionella pneumophila and its role in detoxification of lysophosphatidylcholine.
We previously showed that Legionella pneumophila secretes, via its type II secretion system, phospholipase A activities that are distinguished by their specificity for certain phospholipids. In this study, we identified and characterized plaA, a gene encoding a phospholipase A that cleaves fatty acids from lysophospholipids. The plaA gene encoded a 309-amino-acid protein (PlaA) which had homology to a group of lipolytic enzymes containing the catalytic signature GDSL. In Escherichia coli, the cloned gene conferred trypsin-resistant hydrolysis of lysophosphatidylcholine and lysophosphatidylglycerol. An L. pneumophila plaA mutant was generated by allelic exchange. Although the mutant grew normally in standard buffered yeast extract broth, its culture supernatants lost greater than 80% of their ability to release fatty acids from lysophosphatidylcholine and lysophosphatidylglycerol, implying that PlaA is the major secreted lysophospholipase A of L. pneumophila. The mutant's reduced lipolytic activity was confirmed by growth on egg yolk agar and thin layer chromatography and was complemented by reintroduction of an intact copy of plaA. Overexpression of plaA completely protected L. pneumophila from the toxic effects of lysophosphatidylcholine, suggesting a role for PlaA in bacterial detoxification of lysophospholipids. The plaA mutant grew like the wild type in U937 cell macrophages and Hartmannella vermiformis amoebae, indicating that PlaA is not essential for intracellular infection of L. pneumophila. In the course of characterizing plaA, we discovered that wild-type legionellae secrete a phospholipid cholesterol acyltransferase activity, highlighting the spectrum of lipolytic enzymes produced by L. pneumophila.
Flieger
Antje
A
Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois 60611, Germany.
Neumeister
Birgid
B
Cianciotto
Nicholas P
NP
D000217:Acyltransferases / Q000378:metabolism; D000595:Amino Acid Sequence; D001426:Bacterial Proteins / Q000502:physiology; D004926:Escherichia coli / Q000235:genetics; D005798:Genes, Bacterial; D006801:Humans; D016952:Legionella pneumophila / Q000187:drug effects / Q000201:enzymology / Q000235:genetics*; D008066:Lipolysis; D008244:Lysophosphatidylcholines / Q000378:metabolism* / Q000494:pharmacology; D008245:Lysophospholipase / Q000737:chemistry / Q000235:genetics* / Q000502:physiology; D008666:Metalloendopeptidases / Q000502:physiology; D008969:Molecular Sequence Data; D009154:Mutation; D020298:U937 Cells
D001426:Bacterial Proteins; D008244:Lysophosphatidylcholines; D000217:Acyltransferases; C020597:glycerophospholipid-cholesterol acyltransferase; D008245:Lysophospholipase; D008666:Metalloendopeptidases; C043859:pseudolysin, Pseudomonas aeruginosa